Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ondansetron Lozenge for Post-Spinal Shivering in C-Section
NCT06423807Completed
- Sponsor
- Tanta University
- Start
- May 2024
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of ondansetron in post-spinal shivering (PSS) (2 arms), sponsored by Tanta University. Primary endpoint: Incidence of shivering. Started May 2024; status: completed.
02
Drugs
ondansetron
03
Conditions
post-spinal shivering (PSS)
Beyond the preview
Go deeper on NCT06423807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06423807.